European Healthcare Expenditure on Pharmaceuticals and Medical Non-Durable Goods by All Financing Schemes by Country

In 2023, European healthcare expenditure on pharmaceuticals and medical non-durable goods varied significantly by country, with Switzerland and Liechtenstein having the highest per capita expenditure, and Bosnia and Herzegovina the lowest. Year-on-year variations illustrate trends such as substantial growth in Malta and Slovakia, while Norway saw a slight decline. Over the past five years, countries like Malta and Portugal experienced significant average annual increases in expenditure.

Future trends to watch include the impact of demographic shifts, technological advancements, and policy changes in each country. Attention to innovative medical procedures and real-time tracking of pharmaceutical consumption will be crucial in adapting to future demands.